What were Indraprastha Medical Corporation Ltd's latest quarterly results?
Indraprastha Medical Corporation Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +24.2%
- Revenue Growth YoY: +14.5%
- Operating Margin: 17.0%
Indraprastha Medical Corporation Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 19.3. ROE: 30.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Indraprastha Medical Corporation Ltd's latest quarterly results (Dec 2025) show
Indraprastha Medical Corporation Ltd's current PE ratio is 19.3x.
Indraprastha Medical Corporation Ltd's price-to-book ratio is 5.4x.
Indraprastha Medical Corporation Ltd's fundamental strength based on key financial ratios
Indraprastha Medical Corporation Ltd has a debt-to-equity ratio of N/A.
Indraprastha Medical Corporation Ltd's return ratios over recent years
Indraprastha Medical Corporation Ltd's operating cash flow is positive (FY2025).
Indraprastha Medical Corporation Ltd's current dividend yield is 1.17%.
Indraprastha Medical Corporation Ltd's shareholding pattern (Dec 2025)
Indraprastha Medical Corporation Ltd's promoter holding has remained stable recently.
Indraprastha Medical Corporation Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Indraprastha Medical Corporation Ltd may be worth studying
Indraprastha Medical Corporation Ltd investment thesis summary:
Indraprastha Medical Corporation Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.